表紙:ラテラルフローアッセイの世界市場 (~2026年):用途 (臨床検査 (妊娠・感染症 (蚊媒介・インフルエンザ・STI・肝炎・結核)・心臓マーカー・脂質検査)・獣医・食品安全)・製品 (リーダー・キット)・技術・エンドユーザー別
市場調査レポート
商品コード
1043317

ラテラルフローアッセイの世界市場 (~2026年):用途 (臨床検査 (妊娠・感染症 (蚊媒介・インフルエンザ・STI・肝炎・結核)・心臓マーカー・脂質検査)・獣医・食品安全)・製品 (リーダー・キット)・技術・エンドユーザー別

Lateral Flow Assays Market by Application(Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety) Product(Readers, Kits) Technique, End User - Global Forecast -2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 376 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円
ラテラルフローアッセイの世界市場 (~2026年):用途 (臨床検査 (妊娠・感染症 (蚊媒介・インフルエンザ・STI・肝炎・結核)・心臓マーカー・脂質検査)・獣医・食品安全)・製品 (リーダー・キット)・技術・エンドユーザー別
出版日: 2021年12月15日
発行: MarketsandMarkets
ページ情報: 英文 376 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のラテラルフローアッセイの市場規模は、2021年の96億米ドルから、2026年には114億米ドルに達すると予測され、予測期間中のCAGRは3.4%となります。

世界的な感染症の流行、高齢者人口の急増、ポイントオブケア (POC) テストの需要の高まり、家庭用ラテラルフローアッセイデバイスの使用率の上昇などが、この市場の成長を促す主な要因となっています。一方で、医師や患者が既存の診断方法の変更に消極的であることや、ラテラルフローアッセイの精度が低いことが主な阻害要因となっています。

製品タイプ別では、キット&試薬の部門が2020年に87.5%のシェアを示しています。POC検査へのラテラルフローキット&試薬の応用の増加、慢性疾患の負担の増加、在宅医療でのラテラルフローキットの使用の増加、製品の利便性と使いやすさなどの要因が同部門の成長を推進しています。同部門は予測期間中7.1%の高いCAGRで成長すると予測されています。

当レポートでは、世界のラテラルフローアッセイの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、技術・特許の分析、ケーススタディ、市場規模の推移・予測、製品・用途・キット&試薬技術・臨床検査サンプル・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学:影響分析
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19:経済的評価
  • 経済シナリオに対するCOVID-19の影響の評価
  • ラテラルフローアッセイ市場における経済シナリオに対するCOVID-19の影響の評価
  • 顧客の事業に影響を与える動向・ディスラプション
  • 平均販売価格
  • エコシステム市場マップ
  • 特許分析
  • バリューチェーン分析
  • 技術分析
  • ケーススタディ分析
  • 規制状況
  • ポーターのファイブフォース分析
  • 隣接市場の分析

第6章 ラテラルフローアッセイ市場:製品別

  • キット&試薬
  • ラテラルフローアッセイリーダー
    • デジタル/ハンドヘルドリーダー
    • ベンチトップリーダー
  • 使い捨ておよび再利用可能なラテラルフローアッセイリーダーに関する洞察
  • 臨床診断用途向けのラテラルフローアッセイリーダー市場:タイプ別
    • 製品ポートフォリオ分析

第7章 ラテラルフローアッセイ市場:用途別

  • 臨床試験
    • 感染症検査
    • 心臓マーカー検査
    • 妊娠・出産検査
    • コレステロール/脂質検査
    • 薬物乱用検査
    • その他
  • 獣医診断
  • 食品安全・環境検査
  • 医薬品開発・品質検査

第8章 ラテラルフローアッセイキット&試薬市場:技術別

  • サンドイッチアッセイ
  • 競合アッセイ
  • マルチプレックス検出アッセイ

第9章 臨床検査向けラテラルフローアッセイ市場:サンプルタイプ別

  • 血液サンプル
  • 尿サンプル
  • 唾液サンプル
  • その他

第10章 ラテラルフローアッセイ市場:エンドユーザー別

  • 病院・クリニック
  • 診断ラボ
  • 在宅ケア
  • 製薬・バイオテクノロジー企業
  • その他

第11章 ラテラルフローアッセイ市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • 概要
  • 主要企業の戦略
  • 主要企業の収益シェア分析
  • 市場シェア分析
  • 主要企業のR&D評価
  • 主要企業の地理的収益評価
  • 企業評価クアドラント
  • 中小企業および新興企業の企業評価クアドラント
  • 競合ベンチマーキング
  • 競合シナリオ

第13章 企業プロファイル

  • 主要企業
    • ABBOTT LABORATORIES
    • F. HOFFMANN-LA ROCHE AG
    • QUIDEL CORPORATION
    • DANAHER CORPORATION
    • SIEMENS AG
    • BECTON, DICKINSON AND COMPANY
    • BIOMERIEUX SA
    • BIO-RAD LABORATORIES, INC.
    • THERMO FISHER SCIENTIFIC INC.
    • PERKINELMER INC.
  • その他の企業
    • QIAGEN N.V.
    • MERCK KGAA
    • HOLOGIC, INC.
    • ABCAM PLC
    • SURMODICS IVD
    • CHEMBIO DIAGNOSTIC SYSTEMS, INC.
    • ORASURE TECHNOLOGIES
    • DCN DIAGNOSTICS
    • POLYSCIENCES, INC.
    • ABINGDON HEALTH
    • BIOPORTO DIAGNOSTICS A/S
    • MICROCOAT BIOTECHNOLOGIES GMBH
    • SCIENION AG
    • SENOVA GMBH
    • ACCESS BIO, INC.

第14章 付録

目次
Product Code: MD 4158

The global lateral flow assays market is projected to reach USD 11.4 billion by 2026 from USD 9.6 billion in 2021, at a CAGR of 3.4% during the forecast period. The high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices are the major factors driving the growth of this market. On the other hand, reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key restraints.

"Kits & Reagents segment accounted for the largest share in the lateral flow assays market."

Based on product type, the lateral flow assays market is segmented into kits & reagents and lateral flow readers. In 2020, kits & reagents accounted for the larger share of 87.5% of the global lateral flow assays market. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for POC testing, the growing burden of chronic diseases, the increasing use of lateral flow kits in home care, and their convenience and ease of use. The lateral flow readers segment is bifurcated into digital/handheld readers and benchtop readers. This segment is expected to grow at a higher CAGR of 7.1% during the forecast period.

"Clinical Testing segment is expected to witness the fastest growth in the forecast period."

Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of 89.3% of the lateral flow assays market in 2020. The large share of this segment can be attributed to the rising prevalence of chronic diseases, growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.

"Sandwich assays technique accounted for the largest share of lateral flow assays market in 2020"

Based on technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The sandwich assays technique dominated the lateral flow assays market with a share of 70.9% in 2020. The large share of this segment can be attributed to its better assay sensitivity and specificity and its extensive applications in the measurement of critical analytes (such as cardiac and hepatitis markers).

"Blood samples accounted for the largest share of lateral flow assays market in 2020"

Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Blood samples accounted for the largest market share of 55.9% in 2020. The use of blood samples in lateral flow tests for infectious diseases such as malaria, HIV, and syphilis; the rising awareness of rapid testing solutions; and easy detection of disease antibodies from blood samples are key factors driving the growth of this segment.

"The hospitals & Clinics segment accounted for the largest share of lateral flow assays market in 2020"

Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment accounted for the largest market share of 37.6% in 2020. Technological advancements, the increasing adoption of point-of-care testing and growing patient inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment. The COVID-19 pandemic has also increased the demand for point-of-care testing in professional healthcare settings, further driving the growth of this market in the forecast period.

"North America accounted for the largest share of the lateral flow assays market in 2020"

The North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 38.8% of the lateral flow assays market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. However, the APAC is expected to grow at the highest CAGR of 5.8% during the forecast period. The rapidly developing healthcare industry in China and India, growth in the aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for home and POC testing are supporting market growth in the APAC. The current COVID-19 scenario and its high impact in the Asia Pacific (especially India) have also resulted in a high growth rate in the lateral flow assays market in this region.

A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-20%, and Tier 3-45%
  • By Designation: C-level-45%, Director Level-25%, and Others-30%
  • By Region: North America-36%, Europe-26%, Asia Pacific-21%, Latin America- 10%, and Middle East and Africa- 7%

Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMerieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).

Research Coverage:

The market study covers the lateral flow assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product type, application by technique, by sample type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assays market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE LATERAL FLOW ASSAYS MARKET
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION
    • FIGURE 2 LATERAL FLOW ASSAYS MARKET, BY REGION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
    • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 3 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020)
    • FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2020)
    • FIGURE 7 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON THE MALARIA LATERAL FLOW TESTING MARKET SIZE (2020)
    • FIGURE 8 APPROACH 4: TOP-DOWN APPROACH
    • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE LATERAL FLOW ASSAYS MARKET (2020)
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 KEY INDUSTRY INSIGHTS
  • 2.5 LIMITATIONS
    • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 11 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAYS MARKET

4 PREMIUM INSIGHTS

  • 4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
    • FIGURE 17 RISING COVID-19 PATIENT POPULATION AND GROWTH IN THE PREVALENCE OF INFECTIOUS DISEASES ARE DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET
  • 4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET
    • FIGURE 18 APAC TO REGISTER THE HIGHEST CAGR OF 5.8% DURING THE FORECAST PERIOD
  • 4.3 ASIA PACIFIC LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY
    • FIGURE 19 CLINICAL TESTING SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN ASIA PACIFIC
  • 4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
    • FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATES DURING THE FORECAST PERIOD
  • 4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPING VS DEVELOPED COUNTRIES
    • FIGURE 21 DEVELOPING COUNTRIES TO OFFER HIGHER GROWTH

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High prevalence of infectious diseases across the globe
    • FIGURE 22 PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE
    • TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2020)
      • 5.2.1.2 Rapidly increasing geriatric population
    • FIGURE 23 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)
    • FIGURE 24 GERIATRIC POPULATION, BY COUNTRY, 2020 VS. 2060 (MILLION)
      • 5.2.1.3 Growing usage of home-based lateral flow assay devices
      • 5.2.1.4 Growing demand for point-of-care testing
      • 5.2.1.5 Need for rapid diagnostic testing for COVID-19
    • FIGURE 25 NUMBER OF CONFIRMED CASES OF COVID-19, BY WHO REGION (MILLION)
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Inconsistent results of lateral flow assay tests
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Evolving applications of lateral flow assays
    • TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
      • 5.2.3.2 Rising demand for lateral flow assays in the food & beverage industry
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Limited reimbursements for lateral flow assay products
      • 5.2.4.2 Difficulties in procuring quality raw materials for the development of lateral flow assay tests
  • 5.3 COVID-19 ECONOMIC ASSESSMENT
  • 5.4 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 26 CRITERIA IMPACTING THE GLOBAL ECONOMY
  • 5.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAYS MARKET
  • 5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES (YC-YCC) IN LATERAL FLOW ASSAYS MARKET
    • FIGURE 27 YC-YCC SHIFT IN LATERAL FLOW ASSAYS MARKET
  • 5.7 AVERAGE SELLING PRICE TREND
    • TABLE 4 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020
    • TABLE 5 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS)
  • 5.8 ECOSYSTEM MARKET MAP
    • FIGURE 28 ECOSYSTEM: LATERAL FLOW ASSAYS MARKET (2020)
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAY
    • FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAYS MARKET, 2016-2021
    • 5.9.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAYS PATENTS
    • FIGURE 30 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAYS PATENTS, 2016-2021
    • 5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET
    • FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS PATENTS, 2016-2021
  • 5.10 VALUE CHAIN ANALYSIS
    • FIGURE 32 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2020)
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS
    • 5.11.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
  • 5.12 CASE STUDY ANALYSIS
  • 5.13 REGULATORY LANDSCAPE
    • TABLE 6 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION
    • 5.13.1 NORTH AMERICA
    • 5.13.2 EUROPE
    • 5.13.3 ASIA
      • 5.13.3.1 India
      • 5.13.3.2 China
      • 5.13.3.3 Japan
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 LATERAL FLOW ASSAYS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 THREAT FROM NEW ENTRANTS
    • 5.14.2 THREAT FROM SUBSTITUTES
    • 5.14.3 BARGAINING POWER OF SUPPLIERS
    • 5.14.4 BARGAINING POWER OF BUYERS
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 ADJACENT MARKET ANALYSIS

6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 8 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 6.2 KITS & REAGENTS
    • 6.2.1 INCREASING DEMAND FOR POC TESTING IS DRIVING THE DEMAND FOR KITS & REAGENTS IN THE LATERAL FLOW ASSAYS MARKET
    • TABLE 9 LATERAL FLOW KITS & REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.3 LATERAL FLOW ASSAYS READERS MARKET
    • TABLE 10 EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN THE MARKET
    • TABLE 11 LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
    • TABLE 12 LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 13 LATERAL FLOW READERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 14 LATERAL FLOW READERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 15 LATERAL FLOW READERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.1 DIGITAL/HANDHELD READERS
      • 6.3.1.1 Technological advancements and high accuracy are the major factors driving the growth of the digital/handheld readers market
    • TABLE 16 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 17 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY REGION, 2019-2026 (THOUSAND UNITS)
    • 6.3.2 BENCHTOP READERS
      • 6.3.2.1 Lower diagnosis cost per patient is driving the benchtop readers market
    • TABLE 18 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 19 BENCHTOP LATERAL FLOW READERS VOLUME, REGION, 2019-2026 (THOUSAND UNITS)
  • 6.4 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS
  • 6.5 LATERAL FLOW ASSAYS READERS MARKETS FOR CLINICAL DIAGNOSTICS APPLICATIONS, BY TYPE
    • 6.5.1 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS APPLICATION
    • TABLE 20 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS APPLICATION
    • FIGURE 33 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS (2020)

7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 21 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 7.2 CLINICAL TESTING
    • TABLE 22 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 23 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.1 INFECTIOUS DISEASE TESTING
    • TABLE 24 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 25 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.1 Mosquito-borne diseases
        • 7.2.1.1.1 Increasing incidence of dengue is driving the growth of the lateral flow assays market for mosquito-borne diseases
    • TABLE 26 MAJOR PRODUCTS: DENGUE TESTING
    • TABLE 27 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.2 COVID-19
        • 7.2.1.2.1 The ongoing COVID-19 pandemic to drive the demand for rapid lateral flow tests
    • TABLE 28 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS
    • TABLE 29 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.3 Influenza
        • 7.2.1.3.1 Growing prevalence of influenza globally is expected to boost market growth
    • TABLE 30 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.4 Sexually transmitted infections
    • TABLE 31 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 32 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.1.4.1 HIV
          • 7.2.1.4.1.1 Growing awareness about HIV POC testing is one of the major factors driving market growth
    • TABLE 33 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.1.4.2 HPV
          • 7.2.1.4.2.1 Rising adoption of HPV testing to drive the market during the forecast period
    • TABLE 34 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.1.4.3 Chlamydia
          • 7.2.1.4.3.1 Growing incidence of chlamydia and rising awareness among patients drive market growth
    • TABLE 35 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2019-2026
        • 7.2.1.4.4 Gonorrhea
          • 7.2.1.4.4.1 Rising incidence of gonorrhea globally and increased funding for R&D to drive the lateral flow assays market during the forecast period
    • TABLE 36 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.1.4.5 Syphilis
          • 7.2.1.4.5.1 Growing adoption of novel technologies supporting the growth of the lateral flow assays market for syphilis testing
    • TABLE 37 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.1.4.6 Other sexually transmitted infections
    • TABLE 38 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.5 Hepatitis
        • 7.2.1.5.1 Nucleic acid hybridization-based lateral flow assays hold great potential in the hepatitis testing market
    • TABLE 39 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.6 Tuberculosis
        • 7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment drive the market
    • TABLE 40 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.7 Other infectious diseases
    • TABLE 41 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.2 CARDIAC MARKER TESTING
    • TABLE 42 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 43 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.1 Troponin I & T
        • 7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive this market during the forecast period
    • TABLE 44 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.2 CK-MB
        • 7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive this market
    • TABLE 45 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.3 BNP and NT-proBNP
        • 7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth in this market
    • TABLE 46 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.4 Myoglobin
        • 7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict the growth of the routine myoglobin testing market
    • TABLE 47 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.5 D-Dimer
        • 7.2.2.5.1 Rising incidence of cardiovascular diseases to drive the market for D-dimer tests
    • TABLE 48 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.6 Other cardiac markers
    • TABLE 49 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.3 PREGNANCY & FERTILITY TESTING
    • TABLE 50 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 51 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.3.1 Pregnancy testing
        • 7.2.3.1.1 Pregnancy testing is among the most common application areas for lateral flow assays, registering slower growth during the forecast period
    • TABLE 52 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.3.2 Fertility testing
        • 7.2.3.2.1 Rising infertility rates across the globe driving the demand for POC fertility testing kits
    • TABLE 53 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.4 CHOLESTEROL/LIPID TESTING
      • 7.2.4.1 Growing prevalence of obesity and CVD is the key factor driving market growth
    • TABLE 54 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.5 DRUGS-OF-ABUSE TESTING
      • 7.2.5.1 Technological advancements and growing focus on workplace drug testing are driving market growth
    • TABLE 55 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.6 OTHER CLINICAL TESTS
    • TABLE 56 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 VETERINARY DIAGNOSTICS
    • 7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH
    • TABLE 57 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 FOOD SAFETY & ENVIRONMENT TESTING
    • 7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING
    • TABLE 58 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.5 DRUG DEVELOPMENT & QUALITY TESTING
    • 7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE IS DRIVING THE GROWTH OF THIS MARKET
    • TABLE 59 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2019-2026 (USD MILLION)

8 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE

  • 8.1 INTRODUCTION
    • TABLE 60 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
  • 8.2 SANDWICH ASSAYS
    • 8.2.1 WIDE APPLICATIONS OF SANDWICH ASSAYS IN CLINICAL TESTING CONTRIBUTE TO THE LARGEST SHARE OF THIS SEGMENT
    • TABLE 61 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 COMPETITIVE ASSAYS
    • 8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER GROWTH
    • TABLE 62 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 MULTIPLEX DETECTION ASSAYS
    • 8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE THE GROWTH OF THIS MARKET
    • TABLE 63 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

9 LATERAL FLOW ASSAYS FOR CLINICAL TESTING MARKET, BY SAMPLE TYPE

  • 9.1 INTRODUCTION
    • TABLE 64 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
  • 9.2 BLOOD SAMPLES
    • 9.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE THE GROWTH OF THIS SEGMENT
    • TABLE 65 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 URINE SAMPLES
    • 9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY TESTING AND DRUGS-OF-ABUSE TESTING TO DRIVE THE GROWTH OF THIS MARKET
    • TABLE 66 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.4 SALIVA SAMPLES
    • 9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES ARE THE KEY FACTORS DRIVING MARKET GROWTH
    • TABLE 67 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.5 OTHER SAMPLES
    • TABLE 68 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2019-2026 (USD MILLION)

10 LATERAL FLOW ASSAYS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 69 LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.2 HOSPITALS & CLINICS
    • 10.2.1 INCREASING USE OF POC TESTS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS AMONG HOSPITALS & CLINICS
    • TABLE 70 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 10.3 DIAGNOSTIC LABORATORIES
    • 10.3.1 LABORATORY TESTING IS LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 71 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 10.4 HOME CARE SETTINGS
    • 10.4.1 GROWING ACCEPTANCE OF REMOTE MONITORING DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR HOME CARE
    • TABLE 72 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE THE USE OF LATERAL FLOW ASSAYS AMONG PHARMACEUTICAL & BIOTECH COMPANIES
    • TABLE 73 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 10.6 OTHER END USERS
    • TABLE 74 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)

11 LATERAL FLOW ASSAYS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • FIGURE 34 US TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD
    • TABLE 75 LATERAL FLOW ASSAYS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 11.2 NORTH AMERICA
    • TABLE 76 NORTH AMERICA: MACROECONOMIC INDICATORS
    • FIGURE 35 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
    • TABLE 77 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 78 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 79 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 81 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 83 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 86 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 The US accounts for the largest share of the lateral flow assays market in North America
    • TABLE 89 US: MACROECONOMIC INDICATORS
    • TABLE 90 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 91 US: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 93 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 95 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 99 US: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Availability of research funding and implementation of favorable government initiatives are driving the market in Canada
    • TABLE 101 CANADA: MACROECONOMIC INDICATORS
    • TABLE 102 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 103 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 105 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 106 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 107 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 108 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 111 CANADA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.3 EUROPE
    • FIGURE 36 EUROPE: LATERAL FLOW ASSAYS MARKET SNAPSHOT
    • TABLE 113 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 114 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 115 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 117 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 120 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 121 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 122 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Growing number of POC diagnostics centers to drive the demand for lateral flow assays in Germany
    • TABLE 125 GERMANY: MACROECONOMIC INDICATORS
    • TABLE 126 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 127 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 128 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 129 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 131 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 132 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 133 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 135 GERMANY: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.2 FRANCE
      • 11.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France
    • TABLE 137 FRANCE: MACROECONOMIC INDICATORS
    • TABLE 138 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 139 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 140 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 141 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 142 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 146 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 147 FRANCE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Increasing incidence of chronic diseases and rising prevalence of obesity propelling the market growth in the UK
    • TABLE 149 UK: MACROECONOMIC INDICATORS
    • TABLE 150 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 151 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 153 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 154 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 155 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 156 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 157 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 159 UK: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Growing initiatives towards the decentralization of medical services in Italy are contributing to market growth
    • TABLE 161 ITALY: MACROECONOMIC INDICATORS
    • TABLE 162 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 163 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 164 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 165 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 166 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 168 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 169 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 170 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 171 ITALY: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth
    • TABLE 173 SPAIN: MACROECONOMIC INDICATORS
    • TABLE 174 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 175 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 177 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 179 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 180 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 181 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 182 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 183 SPAIN: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 185 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 186 ROE: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 187 ROE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 188 ROE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 189 ROE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 190 ROE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 191 ROE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 192 ROE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 193 ROE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 194 ROE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 ROE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
    • TABLE 196 APAC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 197 APAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 198 APAC: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 199 APAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 200 APAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 201 APAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 202 APAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 203 APAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 204 APAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 205 APAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 206 APAC: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 207 APAC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assays market in Japan
    • TABLE 208 JAPAN: MACROECONOMIC INDICATORS
    • TABLE 209 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 210 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 211 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 212 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 213 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 214 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 215 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 216 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 217 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 218 JAPAN: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 219 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development is expected to drive market growth in China
    • TABLE 220 CHINA: MACROECONOMIC INDICATORS
    • TABLE 221 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 222 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 223 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 224 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 225 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 226 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 227 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 228 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 229 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 230 CHINA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 231 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Increasing prevalence of chronic disorders, growing healthcare concerns, and rising income levels to propel the growth of this market
    • TABLE 232 INDIA: MACROECONOMIC INDICATORS
    • TABLE 233 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 234 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 235 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 236 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 237 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 238 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 239 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 240 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 241 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 242 INDIA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 243 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.4 AUSTRALIA
      • 11.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assays market
    • TABLE 244 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 245 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 246 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 247 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 248 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 249 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 250 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 251 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 252 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 253 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 254 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.5 REST OF ASIA PACIFIC
    • TABLE 255 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 256 ROAPAC: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 257 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 258 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 259 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 260 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 261 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 262 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 263 ROAPAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 264 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 265 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.5 LATIN AMERICA
    • TABLE 266 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 267 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 268 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 269 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 270 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 271 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 273 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 274 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 275 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 276 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 277 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.5.1 BRAZIL
      • 11.5.1.1 High private healthcare expenditure and increasing geriatric population driving the growth of the lateral flow assays market in the country
    • TABLE 278 BRAZIL: MACROECONOMIC INDICATORS
    • TABLE 279 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 280 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 281 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 282 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 283 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 284 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 285 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 286 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 287 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 288 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 289 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.5.2 MEXICO
      • 11.5.2.1 High prevalence of obesity and related chronic diseases to boost the growth of the lateral flow assays market in the forecast period
    • TABLE 290 MEXICO: MACROECONOMIC INDICATORS
    • TABLE 291 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 292 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 293 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 294 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 295 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 296 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 297 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 298 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 299 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 300 MEXICO: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 301 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.5.3 REST OF LATIN AMERICA
    • TABLE 302 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 303 ROLATAM: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 304 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 305 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 306 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 307 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 308 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 309 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 310 ROLATAM: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 311 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 312 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANSION OF HEALTHCARE SERVICES IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS
    • TABLE 313 AFRICA: MACROECONOMIC INDICATORS
    • TABLE 314 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 315 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 316 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 317 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 318 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 319 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 320 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2029-2026 (USD MILLION)
    • TABLE 321 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 322 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 323 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 324 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • FIGURE 38 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET
  • 12.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAYS MARKET
    • FIGURE 39 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS IN THE LATERAL FLOW ASSAYS MARKET
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 40 LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2020)
    • TABLE 325 LATERAL FLOW ASSAYS MARKET: DEGREE OF COMPETITION
  • 12.5 R&D ASSESSMENT OF KEY PLAYERS
    • FIGURE 41 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET, 2018 VS. 2020
  • 12.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
    • FIGURE 42 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAYS MARKET (2020)
  • 12.7 COMPANY EVALUATION QUADRANT
    • 12.7.1 STARS
    • 12.7.2 PERVASIVE PLAYERS
    • 12.7.3 EMERGING LEADERS
    • 12.7.4 PARTICIPANTS
    • FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX, 2020
  • 12.8 COMPANY EVALUATION QUADRANT FOR SMES & START-UPS
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 DYNAMIC COMPANIES
    • 12.8.3 STARTING BLOCKS
    • 12.8.4 RESPONSIVE COMPANIES
    • FIGURE 44 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR SMES & START-UPS
  • 12.9 COMPETITIVE BENCHMARKING
    • 12.9.1 OVERALL COMPANY FOOTPRINT
    • TABLE 326 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
    • TABLE 327 COMPANY FOOTPRINT: BY PRODUCT (25 COMPANIES)
    • TABLE 328 COMPANY FOOTPRINT: BY TECHNIQUE (25 COMPANIES)
    • TABLE 329 COMPANY FOOTPRINT: BY APPLICATION (25 COMPANIES)
    • TABLE 330 COMPANY FOOTPRINT: BY SAMPLE TYPE (25 COMPANIES)
    • TABLE 331 COMPANY FOOTPRINT: BY END USER (25 COMPANIES)
    • TABLE 332 COMPANY FOOTPRINT: BY REGION (25 COMPANIES)
  • 12.10 COMPETITIVE SCENARIO
    • 12.10.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 333 PRODUCT LAUNCHES & APPROVALS, JANUARY 2018-SEPTEMBER 2021
    • 12.10.2 DEALS
    • TABLE 334 DEALS, JANUARY 2018-SEPTEMBER 2021
    • 12.10.3 EXPANSIONS
    • TABLE 335 EXPANSIONS, JANUARY 2018-SEPTEMBER 2021

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business overview, Solutions offered, Recent developments, COVID-19 Related developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats)**
    • 13.1.1 ABBOTT LABORATORIES
    • TABLE 336 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
    • 13.1.2 F. HOFFMANN-LA ROCHE AG
    • TABLE 337 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
    • FIGURE 46 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2020)
    • 13.1.3 QUIDEL CORPORATION
    • TABLE 338 QUIDEL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020)
    • 13.1.4 DANAHER CORPORATION
    • TABLE 339 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • 13.1.5 SIEMENS AG
    • TABLE 340 SIEMENS AG: BUSINESS OVERVIEW
    • FIGURE 49 SIEMENS AG: COMPANY SNAPSHOT (2020)
    • 13.1.6 BECTON, DICKINSON AND COMPANY
    • TABLE 341 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 13.1.7 BIOMERIEUX SA
    • TABLE 342 BIOMERIEUX SA: BUSINESS OVERVIEW
    • FIGURE 51 BIOMERIEUX SA: COMPANY SNAPSHOT (2020)
    • 13.1.8 BIO-RAD LABORATORIES, INC.
    • TABLE 343 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 52 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
    • 13.1.9 THERMO FISHER SCIENTIFIC INC.
    • TABLE 344 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 53 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
    • 13.1.10 PERKINELMER INC.
    • TABLE 345 PERKINELMER, INC.: BUSINESS OVERVIEW
    • FIGURE 54 PERKINELMER, INC.: COMPANY SNAPSHOT (2020)
  • 13.2 OTHER PLAYERS
    • 13.2.1 QIAGEN N.V.
    • TABLE 346 QIAGEN N. V.: BUSINESS OVERVIEW
    • FIGURE 55 QIAGEN N. V.: COMPANY SNAPSHOT (2020)
    • 13.2.2 MERCK KGAA
    • TABLE 347 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT (2020)
    • 13.2.3 HOLOGIC, INC.
    • TABLE 348 HOLOGIC, INC.: BUSINESS OVERVIEW
    • FIGURE 57 HOLOGIC, INC.: COMPANY SNAPSHOT (2020)
    • 13.2.4 ABCAM PLC
    • TABLE 349 ABCAM PLC: BUSINESS OVERVIEW
    • FIGURE 58 ABCAM PLC.: COMPANY SNAPSHOT (2020)
    • 13.2.5 SURMODICS IVD
    • TABLE 350 SURMODICS IVD: BUSINESS OVERVIEW
    • FIGURE 59 SURMODICS IVD.: COMPANY SNAPSHOT (2020)
    • 13.2.6 CHEMBIO DIAGNOSTIC SYSTEMS, INC.
    • TABLE 351 CHEMBIO DIAGNOSTICS SYSTEMS: BUSINESS OVERVIEW
    • FIGURE 60 CHEMBIO DIAGNOSTIC SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
    • 13.2.7 ORASURE TECHNOLOGIES
    • TABLE 352 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 61 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2020)
    • 13.2.8 DCN DIAGNOSTICS
    • TABLE 353 DCN DIAGNOSTICS: BUSINESS OVERVIEW
    • 13.2.9 POLYSCIENCES, INC.
    • TABLE 354 POLYSCIENCES, INC.: BUSINESS OVERVIEW
    • 13.2.10 ABINGDON HEALTH
    • TABLE 355 ABINGDON HEALTH: BUSINESS OVERVIEW
    • 13.2.11 BIOPORTO DIAGNOSTICS A/S
    • TABLE 356 BIOPORTO DIAGNOSTICS A/S: BUSINESS OVERVIEW
    • FIGURE 62 BIOPORTO DIAGNOSTICS A/S: COMPANY SNAPSHOT (2020)
    • 13.2.12 MICROCOAT BIOTECHNOLOGIES GMBH
    • TABLE 357 MICROCOAT BIOTECHNOLOGIES GMBH: BUSINESS OVERVIEW
    • 13.2.13 SCIENION AG
    • TABLE 358 SCIENION AG: BUSINESS OVERVIEW
    • 13.2.14 SENOVA GMBH
    • TABLE 359 SENOVA GMBH: BUSINESS OVERVIEW
    • 13.2.15 ACCESS BIO, INC.
    • TABLE 360 ACCESS BIO, INC.: BUSINESS OVERVIEW
  • *Business overview, Solutions offered, Recent developments, COVID-19 Related developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS